Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
540788 ASPIRA

Aspira Pathlab & Diagnostics Share Price

 

 

Aspira Pathlab & Diagnostics live price: ₹59.35. It opened at ₹60 vs previous close ₹58; intraday high/low: ₹60/₹56. The 50 & 200 DMA stand at ₹58.72/₹61.22.

Aspira Pathlab & Diagnostics Performance

  • Today's Low
  • ₹56
  • Today's High
  • ₹60
  • 52 Week Low
  • ₹49
  • 52 Week High
  • ₹81
  • Open Price₹60
  • Previous Close₹58
  • Volume673
  • 50 DMA₹58.72
  • 100 DMA₹60.44
  • 200 DMA₹61.22

Aspira Pathlab & Diagnostics Chart

Investment Returns

  • Over 1 Month + 9.91%
  • Over 3 Month -11.42%
  • Over 6 Month -11.26%
  • Over 1 Year -9.53%

Smart Investing Starts Here Start SIP with Aspira Pathlab & Diagnostics for Steady Growth!

Invest Now

Aspira Pathlab & Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 41.6
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 61
  • P/B Ratio
  • 4.7
  • Average True Range
  • 5.72
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.51
  • RSI
  • 54.02
  • MFI
  • 37.65

Aspira Pathlab & Diagnostics Financials

Aspira Pathlab & Diagnostics Technicals

EMA & SMA

Current Price
₹59.35
+ 1.15 (1.98%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹57.40
  • 50 Day
  • ₹58.72
  • 100 Day
  • ₹60.44
  • 200 Day
  • ₹61.22

Resistance and Support

58.36 Pivot Speed
  • R3 64.95
  • R2 62.42
  • R1 60.89
  • S1 56.83
  • S2 54.30
  • S3 52.77

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Aspira Pathlab & Diag has an operating revenue of Rs. 24.24 Cr. on a trailing 12-month basis. An annual revenue growth of 64% is outstanding, Pre-tax margin of 9% is okay, ROE of 27% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 21 which is a POOR score indicating inconsistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 82 indicates it belongs to a poor industry group of Medical-Services and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Aspira Pathlab & Diagnostics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-10 Quarterly Results
2025-11-12 Quarterly Results
2025-08-12 Quarterly Results
2025-05-16 Audited Results
2025-02-07 Quarterly Results

Aspira Pathlab & Diagnostics F&O

Aspira Pathlab & Diagnostics Shareholding Pattern

18.39%
60.06%
21.55%

Aspira Pathlab & Diagnostics FAQs

Aspira Pathlab & Diagnostics share price is ₹59 As on 19 April, 2026 | 15:17

The Market Cap of Aspira Pathlab & Diagnostics is ₹61.1 Cr As on 19 April, 2026 | 15:17

The P/E ratio of Aspira Pathlab & Diagnostics is 41.6 As on 19 April, 2026 | 15:17

The PB ratio of Aspira Pathlab & Diagnostics is 4.7 As on 19 April, 2026 | 15:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23